Filing Overview
Registrant: Agrify Corporation (Nasdaq: AGFY). The request metadata identifies RYTHM, Inc., but the provided Form 8-K is filed by Agrify Corporation.
Reporting date: March 14, 2022; filed March 18, 2022. The filing reports entry into a material financing agreement, creation of debt, and an unregistered securities offering.
Material Financing and Key Terms
- Agrify agreed to sell an accredited investor a $65.0 million senior secured promissory note, less applicable expenses, together with warrants to purchase up to 6,881,108 common shares.
- The note bears interest at 6.75% annually, payable quarterly, and matures on March 1, 2026.
- Beginning February 1, 2023, monthly amortization payments equal to 4.0% of the original principal amount are required through maturity, when all remaining principal and accrued interest are due.
- After the first anniversary, Agrify may pay interest in kind at 8.75% annually, with the interest added to principal.
- Agrify may redeem the note after the first anniversary at 106.75% of outstanding principal plus accrued interest. The investor may require redemption following a fundamental change at 107% of outstanding principal plus accrued interest.
- The warrants have an exercise price of $6.75 per share, are immediately exercisable, and expire five and one-half years after issuance. Cashless exercise is permitted if no effective resale registration statement is available.
- The agreement permits up to two additional closings, each potentially involving a $35.0 million senior secured note and related warrants, subject to specified conditions.
Debt, Liquidity, Covenants, and Default Provisions
- The note is senior secured and ranks ahead of the company’s other indebtedness.
- Covenants restrict additional indebtedness, liens, investments, dividends, and distributions, subject to exceptions.
- Agrify must maintain specified earnings and adjusted EBITDA targets and minimum cash balances; the filing text does not provide the specific thresholds.
- Upon an event of default, the investor may require cash redemption at 115% of outstanding principal, plus accrued interest. Default interest accrues at 15% annually.
- Until repayment, the investor generally has the right to participate in up to 30% of future debt, preferred-stock, or equity-linked financings.
Offering and Registration
The note and warrants were offered in a private placement exempt from registration under Securities Act Section 4(a)(2) and Rule 506(b) of Regulation D. Agrify must file resale registration statements for the warrant shares as soon as practicable and no later than 45 days after each closing. Warrant exercises are subject to beneficial ownership limits initially set at 4.99%, with a potential increase to no more than 9.99% subject to notice and a waiting period.
Outlook, Risks, and Unusual Items
- The financing provides substantial capital but increases secured leverage, interest expense, mandatory amortization, and refinancing obligations through 2026.
- Failure to satisfy financial, cash-balance, or other covenants could trigger default remedies, including a 115% redemption premium and 15% default interest.
- Potential additional closings could increase total debt and equity dilution beyond the initial transaction.
- The warrant issuance and any future exercises may dilute existing shareholders, although exercise is subject to beneficial ownership limitations.
- The filing provides no revenue, profit, cash-flow, margin, or balance-sheet results for the reporting period and includes no formal operating guidance.
Investor Verification Items
- Verify the actual closing date, net cash proceeds, and use of proceeds, which are not clearly provided in the filing text.
- Review the executed note and Securities Purchase Agreement for the precise financial covenants, minimum cash requirement, security interests, and events of default.
- Assess Agrify’s ability to fund the required monthly amortization beginning February 2023 and the final maturity payment in March 2026.
- Confirm whether either of the two additional $35.0 million closings occurs.
- Review subsequent filings for registration of the warrant shares, warrant exercises, additional dilution, and covenant compliance.